University of Patras
Βιοαποικοδομήσιμο σύστημα ελεγχόμενης αποδέσμευσης ακετονικής τριαμσινολόνης για διασκληρική χορήγηση: in vitro μελέτη
Abstract
dc:descriptionTriamcinolone Acetonide (TA) is a synthetic glucocorticoid, which has been widely used to treat a number of inflammatory and vascular and/or exudative diseases of the eye, administered via a peribulbar, sub-tenon or intravitreal injection. Unfortunately, it has a limited half-life and thus repeated injections are often required to establish a prolonged effect. This increases the rate of complications, which are related to the drug itself as well as to the administration route. Study Purpose: To develop scleral controlled-release-systems of Triamcinolone Acetonide based on biodegradable Poly[lactide] (PLA) and evaluate their in vitro/ex vivo properties with regard to their possible application for the prolonged transscleral delivery of TA. Materials and Methods: PLA microspheres containing TA were prepared by a single or double emulsification-solvent evaporation method. Morphology, size, effect of drug input and method of microsphere preparation on drug loading, and in vitro TA release of the microspheres were investigated. Tablets consisting of blank PLA-microspheres and TA (weight ratios of 1:1, 2:1, and 4:1, respectively) were developed and their release profile of TA in vitro was evaluated. The in vitro transscleral diffusion profile was evaluated by placing a PLA-TA (1:1) tablet in a donor chamber and measuring the TA concentration in a receptor chamber. Donor and receptor chambers were separated by rabbit sclera. Two cadaver rabbit eyes received a 1:1 PLA-TA tablet episclerally, which was covered by a scleral patch. TA aqueous humor and vitreous concentrations were measured 5, 10, and 20 days post implantation. Results: Microsphere average diameter was 2 μm. The double emulsification method and increasing drug input led to an increase in microsphere drug loading and encapsulation. Sustained release of TA over several days from the microspheres in vitro was observed, with the rate of release being affected by their TA content. TA exhibited sustained release profile from the PLA-TA tablets, with the rate of release being affected by the PLA:TA ratio. TA could cross the sclera tissue in vitro, with approximately 21% of the initial drug in the donor compartment having diffused through the sclera in 45 days. Following scleral administration of the PLA-TA tablets, TA accumulated in the vitreous and aqueous humor of cadaver eyes. Conclusions: The PLA-TA microspheres and tablets developed in this study provide a sustained and controlled release of TA, provide the advantages of established biodegradability and biocompatibility of the PLA polymer, demonstrate flexibility concerning their TA release rate and total TA dosage and are easy to surgically manipulate. These systems appear promising for the controlled transscleral delivery of TA and justify further investigation.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Blatsios, Georgios
- Μπλάτσιος, Γεώργιος
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25738